Product Liability

Takeda Pharmaceuticals Accused of Neglecting Patient Safety in Actos Marketing

Unfortunately, pharmaceutical companies sometimes put profits ahead of all else. While it seems that patient safety should be at the forefront of a company’s efforts in drug development, some actions can raise questions as to a company’s true priorities. A recent Bloomberg article details the Philadelphia trial of a woman who claims the company marketed its diabetes drug Actos with little regard to patient safety. The plaintiff, who has developed cancer, claimed that the company failed to sufficiently ...

continue reading...

New Jersey Jury Awards $1.58 Million in Accutane Trial Verdict

In the case Rees v. Hoffman-LaRoche, Inc., a New Jersey jury awarded the plaintiff $1,587,928 in what is the ninth straight Accutane trial verdict in favor of plaintiffs. The jury found that the drug could cause ulcerative colitis and that Hoffman-La Roche, its manufacturer, failed to adequately warn of this risk. Trial ran from January 27 to March 10, and the jury rendered its verdict in less than a day.

Accutane was a drug for treatment of ...

continue reading...

GM Emails Suggest Cost a Factor in Faulty Ignition Switch

The New York Times reported today that emails released during ongoing congressional hearings about GM’s faulty ignition switches discussed the cost of fixing the switch.

Based on the emails, which were written in 2005, it appears that the cost of the fixing the switch was a factor in why a change was delayed for years. Several people died in accidents caused by ignition switch failures. Because power to ...

continue reading...

New Study Links Testosterone Supplements to Heart Attacks

A link has been found between the use of testosterone supplements and heart attacks according to a new study. The study authored by epidemiologist William Finkle and researchers at UCLA found that the risk of heart attack in men 65 and older taking testosterone supplements more than doubled with the first 90 days of using the product. The study found that in men under the age of 65 with ...

continue reading...

Senators call for Zohydro investigation

According to The Hill, two senators are investigating allegations that “members of the pharmaceutical industry” paid large sums of money to meet with FDA officials in connection with its recent approval of Zohydro.

The Hill reports that Senators Joe Manchin, (D-WV) and David Vitter (R-LA) have written letters to the FDA and others who may have been involved. According to the letter, multiple pharmaceutical companies paid $25,000 to $30,000 to a university hospital to meet with FDA ...

continue reading...

Zohydro lawsuits predicted after controversial FDA approval

In October, the FDA approved a new hydrocodone-containing pain medication known as Zohydro Extended Release. This approval has caused some controversy among doctors, pain specialists, and addiction organizations, because, according to CNN, it is five times more powerful than other pain medications. If the predictions that Zohydro will cause injury come to pass, then Zohydro lawsuits are likely in the future.

Doctor Concerns about Zohydro

 

According to CNN, pain medication abuse is the leading cause of preventable death, responsible for ...

continue reading...
Page 1 of 132 12345...»